Martin B. Leon, MD, is a Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy (CIVT) at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Leon was the Founder and Chairman Emeritus of the Cardiovascular Research Foundation (CRF) in New York City and is currently CRF’s Co-Director, Medical Research and Education Division. A distinguished pioneer in interventional cardiovascular medicine, Dr. Leon has been the national principal investigator for over 50 clinical trials that have helped shape the field including STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis.
Gary S. Mintz, MD, is Chief Medical Officer of the Cardiovascular Research Foundation, the Managing Co-Director of Transcatheter Cardiovascular Therapeutics (TCT), and Editor-In-Chief of www.tctmd.com. Dr. Mintz has extensive experience in both interventional cardiology and cardiovascular imaging, in particular intravascular imaging and physiology. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program that has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis. He is the author of almost 1000 articles or book chapters and 800 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and intravascular imaging and physiology. In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese.
Jeffrey W. Moses, MD, currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St. Francis Hospital, The Heart Center in Roslyn, NY. Dr. Moses has performed more than 18,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.
Richard A. Shlofmitz, MD, FACC, is Chairman of Cardiology at St. Francis Hospital, The Heart Center, where he has practiced since 1987. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and optical coherence tomography (OCT) world-wide. Dr. Shlofmitz has been one of the largest enrollers for multiple clinical trials, with more than 50 publications in peer-reviewed cardiology journals. Dr. Shlofmitz has worked to advance the field with a focus on Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Physiology Course.
Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital, Roslyn, NY. He is also a member of the Cardiovascular Research Foundation, New York, NY where he currently serves as the Director of the Physiology Core Laboratory. He completed his Medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, as well as Beth Israel Deaconess Medical Center, Harvard Medical School. Dr. Jeremias has numerous publications in the area of coronary physiology and intravascular imaging.
Rasha Al-Lamee, MD, is an interventional cardiology consultant at Imperial College Healthcare NHS Trust. She studied at Oxford University and University College London. She went onto complete her training as a junior doctor on the Barts and the London medical rotation before being appointed as a specialist registrar on the north west London cardiology rotation in 2006. Dr Al-Lamee has eleven years of cardiology experience and completed three years of interventional fellowship training at Hammersmith Hospital in London. She also spent one year training as an interventional fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in cardiology in 2013.
Ziad Ali, MD, is the Victoria and Esther Aboodi Cardiovascular Scientist and Assistant Professor of Medicine at Columbia University Medical Center (CUMC) where he serves as the Associate Director of Translation Research. In addition he is Senior Cardiovascular Scientist at Cardiovascular Research Foundation. Ziad is a practicing coronary and endovascular interventional cardiologist with a specialist interest in complex coronary intervention, intravascular imaging and vascular physiology. In basic science, the goal of the NIH-funded Ali lab at CUMC is to investigate the adverse biological response to cardiovascular injury at a molecular and cellular level. Using systems biology methodologies to investigate signaling events in the propagation of pathogenic conditions they are able to integrate functional genomics and proteomics to identify novel disease mediators.
Andrew Berke, MD, is one of the most experienced interventional cardiologists at St. Francis Hospital. Dr. Berke was principal investigator in numerous national and international clinical trials investigating leading edge, minimally invasive treatments to correct life-threatening cardiac conditions; trials that have included Evalve and CoreValve. He has authored many articles in peer-reviewed scientific journals.
Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Cardiac Catheterization Laboratory at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.
Cindy Grines, MD, is the Chair of Cardiology at Hofstra Northwell School of Medicine. Previously, Dr. Grines was vice president of academic and clinical affairs at Detroit Medical Center’s Heart Hospital. Before joining the Detroit hospital in 2011, Dr. Grines was vice chief of cardiovascular medicine at the Beaumont Hospital in Royal Oak, MI, where she spent two decades. Dr. Grines led numerous multicenter clinical trials, including the PAMI trial that demonstrated primary PCI was superior to clot busting drugs and the Stent PAMI study, which confirmed the benefits of stents versus angioplasty for treating heart attacks. Research led by Dr. Grines revolutionized the management of heart attack patients across the world. She has published more than 400 publications, numerous book chapters and hundreds of medical journal articles regarding cardiac catheterization, PCI, acute myocardial infarction, gene therapy and heart disease in women. She is the editor-in-chief of the Journal of Interventional Cardiology.
Giulio Guagliumi, MD, is the Director of the Clinical Research Program at Interventional Cardiology of Ospedale Papa Giovanni XXIII Bergamo, Italy. He was trained with Master in Interventional Cardiology at the Clinique Pasteur, Toulouse, France. He has a long-standing research expertise in coronary interventions, particularly in the field of high resolution intravascular imaging, acute myocardial infarction and stent vascular biology. Dr. Guagliumi has authored publications in cardiovascular research and clinical trials across all prestigious cardiology journals. He is fellow of the ESC, member of the board of EAPCI, expert-chair for the scientific program in interventional cardiology at the ESC Congress.
Jonathan Hill, MD, graduated from Edinburgh University Medical School in 1992 following pre clinical training at Cambridge University. He trained in cardiology at The London Chest and St Bartholomew’s Hospitals. In 1999 he was awarded the first National Heart Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda. He completed his interventional cardiology training at the London Chest Hospital. In 2005, appointed Clinical Senior Lecturer and Consultant Cardiologist at King’s College London. He continues with his research programme relating to stem and progenitor cells in cardiovascular disease and is a practising interventional cardiologist with a special interest in acute myocardial infarction and new biological therapy.
Cezar Iliescu, MD, FACC, FSCAI, is the Director of the Cardiac Catheterization Laboratory and Associate Professor at The University of Texas MD Anderson Cancer Center in Houston, TX. He is an interventional cardiologist interested in vascular biology in cancer patients, endovascular treatment of patients with chronic thrombocytopenia, physiologic assessment of coronary stenosis, treatment of radiation induced cardiovascular disease.
Dimitrios Karmpaliotis, MD, PhD, is a member of the Center for Interventional Vascular Therapy at Columbia University Medical Center. Dr. Karmpaliotis specializes in advanced, complex coronary intervention. He brings a wealth of experience in percutaneous coronary interventions. Dr. Karmpaliotis graduated from the University of Athens School of Health Sciences and trained at the prestigious Beth Israel Deaconess Medical Center at Harvard Medical School. Dr. Karmpaliotis was instrumental in building a world-class interventional cardiology program at Piedmont Heart Center in Atlanta, Georgia and has contributed to building one of the largest complex PCI programs in the world at CUMC. He also serves as the co-director of the US CTO Summit Dr. Karmpaliotis has served as principal investigator on more than 50 clinical trials, with special interest in the development of techniques for treating chronic total occlusions in coronary arteries.
Ajay J. Kirtane, MD, SM, specializes in complex coronary and peripheral vascular interventional procedures. Dr.Kirtane assumes the directorship of the New York-Presbyterian/ Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of numerous international, national, and regional educational meetings. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions, and he is/has been Principal Investigator for several multicenter trials in interventional cardiovascular medicine.
Michael S. Lee, MD, is an interventional cardiologist and Associate Professor of Medicine at the UCLA Medical Center.
Akiko Maehara, MD, is an assistant professor of medicine at Columbia University College of Physicians and Surgeons in New York City and has authored numerous papers related to cardiovascular interventions and the use of intravascular ultrasound. She received her medical degree in from Yamaguchi University School of Medicine in Yamaguchi, Japan, and is board certified in internal medicine and cardiology by the Japanese Society of Internal Medicine and Japanese Society of Cardiology. Dr. Maehara completed her clinical fellowship at the Toranomon Hospital in Tokyo, Japan, and a cardiovascular fellowship at the Cardiovascular Center at Toranomon Hospital. Dr. Maehara finished a research fellowship in cardiovascular interventions at Stanford University School of Medicine in Stanford, California, with an additional fellowship year at the Cardiovascular Research Institute of the Washington Hospital Center in Washington, DC.
Thomas Pappas, MD, is Director of St. Francis Hospital’s Cardiac Catheterization Laboratory. In this capacity, he has participated in numerous clinical trials evaluating novel coronary interventional devices. He is a graduate of Cornell University Medical College, practicing both interventional as well as consultative cardiology for the past 25 years at St. Francis Hospital. Dr. Pappas has consistently been recognized by Newsday and Castle Connolly as one of the top physicians on Long Island and has been selected as one of New York magazine’s Best Doctors.
Evelyn Regar, MD, PhD, FESC, is currently engaged as Consultant Director of Research with the Department of Cardiovascular Surgery at the University Hospital of Zürich, Switzerland. Prior to that she spent several years as a interventional cardiologist at the ThoraxCenter of the Erasmus Medical Center in The Netherlands. Dr. Regar did her preclinical studies at the University of Regensburg, Germany, before training at the Technical University of Munich. From there, she trained in internal medicine and cardiology at the University Hospital, also in Munich. She has authored of more than 300 original articles in peer-reviewed major scientific journals, as well as several books and book chapters.
Paul Teirstein, MD, is the chief of cardiology and director of interventional cardiology for Scripps Clinic and director of the Scripps Prebys Cardiovascular Institute for Scripps Health. He received training at the Mount Sinai School of Medicine, the Brigham and Women’s Hospital, Stanford University, the Mid-America Heart Institute, and the National Institutes of Health. Dr. Teirstein joined Scripps in 1987 and is the founder and director of the interventional cardiology program at Scripps Clinic. Through this program he is leading the way in training a new generation of interventional cardiologists.